---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-011717"
form_type: "8-K"
ticker: "GPCR"
cik: "0001888886"
company_name: "Structure Therapeutics Inc."
filed_at: "2023-02-07T23:59:59+00:00"
generated_at: "2026-06-19T23:15:30.165397+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Structure Therapeutics adopts restated articles authorizing 500M ordinary shares, effective upon IPO closing

## Summary
- Filed restated memorandum and articles on Feb 3, 2023, effective Feb 7, 2023 upon IPO closing.
- Authorizes 500,000,000 ordinary shares; details previously reported in Registration Statement on Form S-1.
- Seventh amended and restated memorandum and articles of association filed as Exhibit 3.1.

## SEC filing metadata
- accession: 0001104659-23-011717
- form_type: 8-K
- ticker: GPCR
- cik: 0001888886
- company_name: Structure Therapeutics Inc.
- filed_at: 2023-02-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1888886/000110465923011717/0001104659-23-011717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1888886/000110465923011717/tm235639d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-011717
- JSON: https://secwatch.observer/filing/0001104659-23-011717.json
- Plain text: https://secwatch.observer/filing/0001104659-23-011717.txt

## Key facts
- Governance Changes
  Structure Therapeutics Inc.: Filed amended and restated memorandum and articles of association to authorize 500,000,000 ordinary shares, effective upon IPO closing (effective 2023-02-07).
  - Change: charter amendment
  - Effective: 2023-02-07
  source text: On February 3, 2023, and in connection with the consummation of Structure Therapeutics Inc.’s (the “Company”) initial public offering of its American Depositary Shares representing its ordinary shares (the “IPO”), the Company filed an amended and restated memorandum and articles of association (the “Restated Memorandum and Articles”), substantially in the form previously filed as Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (File No. 333-269200) (as amended, the “Registration Statement”), with the Registrar of Companies of the Cayman Islands. The Restated Memorandum and Articles each became effective upon the closing of the Offering on February 7, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1888886/000110465923011717/0001104659-23-011717-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.